<?xml version="1.0" encoding="UTF-8"?>
<ref id="B118">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Moses</surname>
    <given-names>R. A.</given-names>
   </name>
   <name>
    <surname>Anderson</surname>
    <given-names>R. E.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Keihani</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Craig</surname>
    <given-names>J. R.</given-names>
   </name>
   <name>
    <surname>Myers</surname>
    <given-names>J. B.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2019</year>). 
  <article-title>Erectile dysfunction management after failed phosphodiesterase-5-inhibitor trial: a cost-effectiveness analysis</article-title>. 
  <source>Transl. Androl. Urol.</source>
  <volume>8</volume> (
  <issue>4</issue>), 
  <fpage>387</fpage>â€“
  <lpage>394</lpage>. 
  <pub-id pub-id-type="doi">10.21037/tau.2019.03.1010.21037/tau.2019.03.10</pub-id>
  <pub-id pub-id-type="pmid">31555563</pub-id>
 </mixed-citation>
</ref>
